Radiolabelled synthesis of (R)-methadone
Ended Purchase Order Awarded
- Contract number
- 75N95C22P00106
- Awardee
-
Novandi Chemistry AB UEI PUC7QCM2EAK8
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,900
Award facts
- Contract value 100% obligated
- $14,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Sweden
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95C22P00106?
75N95C22P00106 was awarded to Novandi Chemistry AB by National Center for Advancing Translational Sciences (National Institutes of Health) on August 28, 2022.
How much is contract 75N95C22P00106 worth?
The government has obligated $14,900 on 75N95C22P00106.
Was contract 75N95C22P00106 competed?
The extent of competition for 75N95C22P00106 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award